Fawad Muhammad, Abbas Muhammad, Zhang Limin, Zhang Yuping, Guo Yaxiong
Institute of Microcirculation, Hebei North University Zhangjiakou Hebei China
RSC Adv. 2019 Feb 8;9(9):4870-4875. doi: 10.1039/c8ra08473d. eCollection 2019 Feb 5.
The return of post-hemorrhagic shock mesenteric lymph (PHSML) induces pulmonary vascular endothelial barrier dysfunction, which results in acute lung injury. Activation of the apoptosis signal-regulated kinase 1 (ASK1) and p38 mitogen-activated protein kinase (p38 MAPK) pathway has been shown to trigger inflammatory responses. However, whether the ASK1-p38 MAPK pathway is involved in the PHSML-induced pulmonary endothelial barrier dysfunction remains unclear. In the present study, permeability changes of pulmonary capillaries were found , and activation of the ASK1-p38 MAPK pathway was determined . PMVEC barrier dysfunction was determined by measuring TEER. Furthermore, junctional and cytoskeletal protein expressions were analyzed. The results showed that hemorrhagic shock led to a marked increase in the permeability of pulmonary capillaries , which was markedly alleviated by PHSML drainage. In cultured pulmonary microvascular endothelial cells (PMVECs), PHSML reduced the endothelial barrier function accompanied by upregulated p-ASK1 and p-p38 MAPK protein expression, impaired the cytoskeletal protein structure, and down-regulated junction protein expression. These adverse effects were eliminated by applying either Trx1 (ASK1 inhibitor) or SB203580 (p38 MAPK inhibitor). These results indicated that the ASK1-p38 MAPK pathway mediates PHSML-induced pulmonary vascular endothelial barrier dysfunction during hemorrhagic shock.
出血性休克后肠系膜淋巴液(PHSML)的回输可导致肺血管内皮屏障功能障碍,进而引发急性肺损伤。凋亡信号调节激酶1(ASK1)和p38丝裂原活化蛋白激酶(p38 MAPK)通路的激活已被证明可触发炎症反应。然而,ASK1-p38 MAPK通路是否参与PHSML诱导的肺内皮屏障功能障碍仍不清楚。在本研究中,发现了肺毛细血管通透性的变化,并确定了ASK1-p38 MAPK通路的激活情况。通过测量跨上皮电阻(TEER)来确定肺微血管内皮细胞(PMVEC)屏障功能障碍。此外,还分析了连接蛋白和细胞骨架蛋白的表达。结果表明,出血性休克导致肺毛细血管通透性显著增加,而PHSML引流可明显缓解这种情况。在培养的肺微血管内皮细胞(PMVECs)中,PHSML降低了内皮屏障功能,同时p-ASK1和p-p38 MAPK蛋白表达上调,细胞骨架蛋白结构受损,连接蛋白表达下调。应用Trx1(ASK1抑制剂)或SB203580(p38 MAPK抑制剂)可消除这些不良反应。这些结果表明,ASK1-p38 MAPK通路在出血性休克期间介导了PHSML诱导的肺血管内皮屏障功能障碍。